{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:55:06Z","timestamp":1791417306046,"version":"4.3.3"},"reference-count":114,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":623,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.ijid.2011.07.007","type":"journal-article","created":{"date-parts":[[2011,9,26]],"date-time":"2011-09-26T10:15:26Z","timestamp":1317032126000},"page":"e732-e739","source":"Crossref","is-referenced-by-count":334,"title":["The revival of fosfomycin"],"prefix":"10.1016","volume":"15","author":[{"given":"Argyris S.","family":"Michalopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis G.","family":"Livaditis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilios","family":"Gougoutas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2011.07.007_bib0005","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1126\/science.166.3901.122","article-title":"Phosphonomycin. A new antibiotic produced by strains of Streptomyces","volume":"166","author":"Hendlin","year":"1969","journal-title":"Science"},{"key":"10.1016\/j.ijid.2011.07.007_bib0010","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1086\/527442","article-title":"Fosfomycin: use beyond urinary tract and gastrointestinal infections","volume":"46","author":"Falagas","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.ijid.2011.07.007_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000222020","article-title":"Fosfomycin: laboratory studies","volume":"23","author":"Woodruff","year":"1977","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijid.2011.07.007_bib0020","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/AAC.35.5.791","article-title":"Plasmid-encoded fosfomycin resistance","volume":"35","author":"Su\u00e1rez","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0025","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1749-6632.1974.tb43277.x","article-title":"The mechanism of action of fosfomycin (phosphonomycin)","volume":"235","author":"Kahan","year":"1974","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ijid.2011.07.007_bib0030","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1128\/AAC.26.5.789","article-title":"Synergistic activities of combination of beta lactams, fosfomycin, and tobramycin against Pseudomonas aeruginosa","volume":"26","author":"Takahashi","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0035","first-page":"943","article-title":"Synergy of fosfomycin with beta-lactam antibiotics against staphylococci and aerobic Gram-negative bacilli","volume":"12","author":"Chin","year":"1986","journal-title":"Drugs Exp Clin Res"},{"key":"10.1016\/j.ijid.2011.07.007_bib0040","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s101560200004","article-title":"Effectiveness of fosfomycin combined with other antimicrobial agents against multidrug-resistant Pseudomonas aeruginosa isolates using the efficacy time index assay","volume":"8","author":"Okazaki","year":"2002","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0045","series-title":"Kucers\u2019 the use of antibiotics","author":"Grayson","year":"2010"},{"issue":"Suppl 1","key":"10.1016\/j.ijid.2011.07.007_bib0050","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000472864","article-title":"Pharmacokinetic profile of fosfomycin trometamol (Monuril)","volume":"13","author":"Segre","year":"1987","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijid.2011.07.007_bib0055","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/jac\/dkg187","article-title":"Target site penetration of fosfomycin in critically ill patients","volume":"51","author":"Joukhadar","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0060","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1128\/AAC.47.1.371-374.2003","article-title":"Penetration of fosfomycin into inflammatory lesions in patients with cellulitis or diabetic foot syndrome","volume":"47","author":"Legat","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0065","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/jac\/dkq070","article-title":"Extracellular concentrations of fosfomycin in lung tissue of septic patients","volume":"65","author":"Matzi","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0070","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/jac\/dkp230","article-title":"High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection","volume":"64","author":"Schintler","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0075","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1128\/AAC.44.10.2728-2732.2000","article-title":"Distribution and antimicrobial activity of fosfomycin in the interstitial fluid of human soft tissues","volume":"44","author":"Frossard","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0080","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1128\/AAC.49.11.4448-4454.2005","article-title":"Antibiotic abscess penetration: fosfomycin levels measured in pus and simulated concentration\u2013time profiles","volume":"49","author":"Sauermann","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0085","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/BF01647220","article-title":"Penetration of fosfomycin into cerebrospinal fluid across non-inflamed and inflamed meninges","volume":"15","author":"Kuhnen","year":"1987","journal-title":"Infection"},{"key":"10.1016\/j.ijid.2011.07.007_bib0090","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/jac\/dkp261","article-title":"Cerebrospinal fluid impairs antimicrobial activity of fosfomycin in vitro","volume":"64","author":"Sauermann","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0095","first-page":"15","article-title":"Fosfomycin","volume":"16","author":"Gobernado","year":"2003","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.ijid.2011.07.007_bib0100","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/jac\/dkh158","article-title":"Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis","volume":"53","author":"Pfausler","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0105","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ijantimicag.2010.01.010","article-title":"Antimicrobial susceptibility of Gram-positive non-urinary isolates to fosfomycin","volume":"35","author":"Falagas","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2011.07.007_bib0110","series-title":"Performance standards for antimicrobial susceptibility testing. 20th informational supplement","author":"Clinical and Laboratory Standards Institute","year":"2010"},{"key":"10.1016\/j.ijid.2011.07.007_bib0115","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1128\/AAC.50.1.368-370.2006","article-title":"In vitro activity of fosfomycin against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: comparison of susceptibility testing procedures","volume":"50","author":"de Cueto","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0120","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/jac\/dkl047","article-title":"Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae","volume":"57","author":"Ribes","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0125","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1179\/joc.2001.13.5.535","article-title":"Time-kill evaluation of antimicrobial regimens against clinical isolates of penicillin-resistant Streptococcus pneumoniae","volume":"13","author":"Banon Arias","year":"2001","journal-title":"J Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.patbio.2004.10.009","article-title":"Antibiotics resistance of methicillin-resistant Staphylococcus aureus: detection of the first glycopeptides low sensibility strains in Tunisia","volume":"54","author":"Mastouri","year":"2006","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.ijid.2011.07.007_bib0135","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/jac\/43.2.211","article-title":"In-vitro activity of fosfomycin against vancomycin-resistant enterococci","volume":"43","author":"Allerberger","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0140","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/jac\/35.1.228","article-title":"Antibacterial spectrum of fosfomycin trometamol","volume":"35","author":"Barry","year":"1995","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0145","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1157\/13095372","article-title":"Activity of fosfomycin against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae","volume":"24","author":"de Cueto","year":"2006","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.ijid.2011.07.007_bib0150","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijantimicag.2009.03.009","article-title":"Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies","volume":"34","author":"Falagas","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2011.07.007_bib0155","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jac\/38.6.1107","article-title":"In vitro activity of antimicrobial agent combinations against multiresistant Acinetobacter baumannii","volume":"38","author":"Martinez-Martinez","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0160","first-page":"1239","article-title":"In vitro activity of fosfomycin\u2013gentamicin, fosfomycin\u2013ceftazidime, fosfomycin\u2013imipenem and ceftazidime\u2013gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa","volume":"36","author":"Pruekprasert","year":"2005","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.ijid.2011.07.007_bib0165","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1569-1993(02)00143-1","article-title":"Fosfomycin therapy for multiresistant Pseudomonas aeruginosa in cystic fibrosis","volume":"2","author":"Mirakhur","year":"2003","journal-title":"J Cyst Fibros"},{"issue":"Suppl 1","key":"10.1016\/j.ijid.2011.07.007_bib0170","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000222026","article-title":"In vitro sensitivity of anaerobic bacteria to fosfomycin","volume":"23","author":"Alt\u00e9s Guti\u00e9rrez","year":"1977","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijid.2011.07.007_bib0175","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1473-3099(09)70325-1","article-title":"Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review","volume":"10","author":"Falagas","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2011.07.007_bib0180","first-page":"121","article-title":"Activity of fosfomycin against extended-spectrum-\u03b2-lactamase producing Klebsiella pneumoniae and Escherichia coli in Maharaj Nakorn Chiang Mai Hospital","volume":"22","author":"Tharavichitkul","year":"2005","journal-title":"J Infect Dis Antimicrob Agents"},{"key":"10.1016\/j.ijid.2011.07.007_bib0185","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1128\/JCM.41.8.3893-3896.2003","article-title":"VIM-1 Metallo-beta-lactamase producing Klebsiella pneumoniae strains in Greek hospitals","volume":"41","author":"Giakkoupi","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2011.07.007_bib0190","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1128\/AAC.01235-09","article-title":"In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those non-susceptible to tigecycline and\/or colistin","volume":"54","author":"Endimiani","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0195","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2217\/fmb.10.47","article-title":"Antimicrobial susceptibility of Gram-negative nonurinary bacteria to fosfomycin and other antimicrobials","volume":"5","author":"Samonis","year":"2010","journal-title":"Future Microbiol"},{"key":"10.1016\/j.ijid.2011.07.007_bib0200","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ijantimicag.2007.05.005","article-title":"Activity and penetration of fosfomycin, ciprofloxacin, amoxicillin\/clavulanic acid and co-trimoxazole in Escherichia coli and Pseudomonas aeruginosa biofilms","volume":"30","author":"Rodr\u00edguez-Mart\u00ednez","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2011.07.007_bib0205","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s10156-002-0186-6","article-title":"Role of fosfomycin in a synergistic combination with ofloxacin against Pseudomonas aeruginosa growing in a biofilm","volume":"8","author":"Monden","year":"2002","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0210","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10156-007-0534-7","article-title":"Treatment of Pseudomonas aeruginosa biofilms with a combination of fluoroquinolones and fosfomycin in a rat urinary tract infection model","volume":"13","author":"Mikuniya","year":"2007","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0215","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/jac\/dkp224","article-title":"Synergistic effects of aminoglycosides and fosfomycin on Pseudomonas aeruginosa in vitro and biofilm infections in a rat model","volume":"64","author":"Cai","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0220","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10156-010-0167-0","article-title":"Antibiotic time-lag combination therapy with fosfomycin for postoperative intra-abdominal abscesses","volume":"17","author":"Kusachi","year":"2011","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0225","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1574-6968.1989.tb03566.x","article-title":"Plasmid-mediated resistance to fosfomycin in Staphylococcus epidermidis","volume":"52","author":"Etienne","year":"1989","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.ijid.2011.07.007_bib0230","doi-asserted-by":"crossref","first-page":"17786","DOI":"10.1074\/jbc.M501052200","article-title":"Functional analysis of active site residues of the fosfomycin resistance enzyme FosA from Pseudomonas aeruginosa","volume":"280","author":"Beharry","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijid.2011.07.007_bib0235","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1128\/AAC.43.4.789","article-title":"Emergence of fosfomycin-resistant isolates of Shiga-like toxin-producing Escherichia coli O26","volume":"43","author":"Horii","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0240","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/jac\/34.6.955","article-title":"Detection of fosfomycin resistance by the polymerase chain reaction and Western blotting","volume":"34","author":"Garc\u00eda","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0245","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1128\/AAC.32.10.1552","article-title":"Formation of an adduct between fosfomycin and glutathione: a new mechanism of antibiotic resistance in bacteria","volume":"32","author":"Arca","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0250","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1128\/AAC.34.5.844","article-title":"Purification of a glutathione S-transferase that mediates fosfomycin resistance in bacteria","volume":"34","author":"Arca","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0255","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1128\/JB.183.7.2380-2383.2001","article-title":"FosB, a cysteine-dependent fosfomycin resistance protein under the control of sigma(W), an extracytoplasmic-function sigma factor in Bacillus subtilis","volume":"183","author":"Cao","year":"2001","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijid.2011.07.007_bib0260","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1021\/bi963172a","article-title":"Fosfomycin resistance protein (FosA) is a manganese metalloglutathione transferase related to glyoxalase I and the extradiol dioxygenases","volume":"36","author":"Bernat","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijid.2011.07.007_bib0265","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0076-6879(05)01023-2","article-title":"Fosfomycin resistance proteins: a nexus of glutathione transferases and epoxide hydrolases in a metalloenzyme superfamily","volume":"401","author":"Rigsby","year":"2005","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.ijid.2011.07.007_bib0270","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/jac\/40.3.393","article-title":"Plasmid-encoded fosfomycin resistance in bacteria isolated from the urinary tract in a multicentre survey","volume":"40","author":"Arca","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0275","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/jac\/34.6.853","article-title":"Fosfomycin trometamol","volume":"34","author":"Reeves","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0280","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1086\/321815","article-title":"Vancomycin-resistant enterococci: mechanisms and clinical observations","volume":"33","author":"Gold","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2011.07.007_bib0285","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1128\/JCM.43.2.925-927.2005","article-title":"Quality control guidelines for testing Gram-negative control strains with polymyxin B and colistin (polymyxin E) by standardized methods","volume":"43","author":"Jones","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2011.07.007_bib0290","first-page":"420","article-title":"Prevention of recurrent lower urinary tract infections by long-term administration of fosfomycin trometamol. Double blind, randomized, parallel group, placebo controlled study","volume":"55","author":"Rudenko","year":"2005","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ijid.2011.07.007_bib0295","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/jac\/dkq237","article-title":"Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials","volume":"65","author":"Falagas","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0300","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijantimicag.2006.08.039","article-title":"Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections","volume":"29","author":"Pullukcu","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2011.07.007_bib0305","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1001\/archinte.168.17.1897","article-title":"Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli","volume":"168","author":"Rodr\u00edguez-Ba\u00f1o","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijid.2011.07.007_bib0310","first-page":"104","article-title":"Fosfomycin tromethamine: single-dose treatment of acute cystitis","volume":"44","author":"Stein","year":"1999","journal-title":"Int J Fertil Womens Med"},{"issue":"Suppl 2","key":"10.1016\/j.ijid.2011.07.007_bib0315","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0924-8579(03)00231-0","article-title":"Why fosfomycin trometamol as first line therapy for uncomplicated UTI?","volume":"22","author":"Schito","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2011.07.007_bib0320","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1086\/649865","article-title":"An outbreak of infection due to beta-lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes","volume":"50","author":"Souli","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2011.07.007_bib0325","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1469-0691.2009.02921.x","article-title":"Intravenous fosfomycin for the treatment of nosocomial infections due to carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation","volume":"16","author":"Michalopoulos","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2011.07.007_bib0330","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s10156-009-0703-y","article-title":"Characterization of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR) in a patient with septicemia during long-term vancomycin administration","volume":"15","author":"Yamaguchi","year":"2009","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0335","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/112067219600600207","article-title":"Ocular penetration kinetics of fosfomycin administered as a one-hour infusion","volume":"6","author":"Forestier","year":"1996","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ijid.2011.07.007_bib0340","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10096-009-0833-2","article-title":"Fosfomycin: an old, new friend?","volume":"29","author":"Popovic","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2011.07.007_bib0345","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/BF01644014","article-title":"Adjuvant fosfomycin medication in chronic osteomyelitis","volume":"17","author":"Meissner","year":"1989","journal-title":"Infection"},{"key":"10.1016\/j.ijid.2011.07.007_bib0350","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijantimicag.2010.09.002","article-title":"Adverse events associated with intravenous fosfomycin","volume":"37","author":"Florent","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2011.07.007_bib0355","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF01644178","article-title":"Haematogenous Serratia marcescens endophthalmitis in an HIV-infected intravenous drug addict","volume":"18","author":"Alvarez","year":"1990","journal-title":"Infection"},{"key":"10.1016\/j.ijid.2011.07.007_bib0360","first-page":"525","article-title":"Treatment of ventriculitis caused by Staphylococcus epidermidis on equipment with the combination of fosfomycin and an aminoglycoside. Course of ventricular levels of fosfomycin","volume":"31","author":"Boulard","year":"1983","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.ijid.2011.07.007_bib0365","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/0036554021000027022","article-title":"Postoperative spondylodiskitis due to Stomatococcus mucilaginosus in an immunocompetent patient","volume":"35","author":"Bureau-Chalot","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijid.2011.07.007_bib0370","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jbspin.2004.01.009","article-title":"Suspected disk space infection with negative microbiological tests\u2014report of eight cases and comparison with documented pyogenic discitis","volume":"72","author":"Gillard","year":"2005","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.ijid.2011.07.007_bib0375","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/jac\/dki280","article-title":"Bacterial prostatitis due to Pseudomonas aeruginosa harbouring the blaVIM-2 metallo-\u03b2-lactamase gene from Saudi Arabia","volume":"56","author":"Guerin","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"5 Pt 2","key":"10.1016\/j.ijid.2011.07.007_bib0380","first-page":"839","article-title":"Treatment of post-traumatic and post-neurosurgical bacterial meningitis with ceftriaxone alone or in combination with fosfomycin","volume":"35","author":"May","year":"1987","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.ijid.2011.07.007_bib0385","first-page":"994","article-title":"A case of toxic shock syndrome induced by MRSA after sinus surgery","volume":"45","author":"Nakayama","year":"1996","journal-title":"Masui"},{"key":"10.1016\/j.ijid.2011.07.007_bib0390","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/BF01644272","article-title":"Fosfomycin\u2013ampicillin versus gentamicin\u2013ampicillin in the treatment of critically ill patients with pneumonia","volume":"14","author":"Nissen","year":"1986","journal-title":"Infection"},{"key":"10.1016\/j.ijid.2011.07.007_bib0395","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1528-1157.2001.23800.x","article-title":"Deep wound infection after vagus nerve stimulator implantation: treatment without removal of the device","volume":"42","author":"Ortler","year":"2001","journal-title":"Epilepsia"},{"issue":"Suppl 1","key":"10.1016\/j.ijid.2011.07.007_bib0400","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1007\/BF01644232","article-title":"Cefotaxime in combination with other antibiotics for the treatment of severe methicillin-resistant staphylococcal infections","volume":"13","author":"Portier","year":"1985","journal-title":"Infection"},{"key":"10.1016\/j.ijid.2011.07.007_bib0405","first-page":"390","article-title":"Infection of the valves of CSF shunts: results of local and general antibiotic treatment in 6 cases","volume":"31","author":"Roualdes","year":"1985","journal-title":"Neurochirurgie"},{"key":"10.1016\/j.ijid.2011.07.007_bib0410","first-page":"2498","article-title":"A patient with acute leukemia and meningitis caused by Staphylococcus epidermidis treated with fosfomycin","volume":"139","author":"Silbermann","year":"1995","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.ijid.2011.07.007_bib0415","first-page":"311","article-title":"Clinical evaluation of high dose intravenous injection of fosfomycin on the severe infections associated with the treatment of haematological disorders","volume":"36","author":"Ueda","year":"1983","journal-title":"Jpn J Antibiot"},{"key":"10.1016\/j.ijid.2011.07.007_bib0420","first-page":"61","article-title":"Non-surgical management of an infected ventriculo-atrial shunt","volume":"32","author":"Zink","year":"1989","journal-title":"Neurochirurgia (Stuttg)"},{"key":"10.1016\/j.ijid.2011.07.007_bib0425","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s10156-007-0544-5","article-title":"Randomized prospective comparison of fosfomycin and cefotiam for prevention of postoperative infection following urological surgery","volume":"13","author":"Ishizaka","year":"2007","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0430","first-page":"181","article-title":"Fosfomycin\/metronidazole compared with doxycycline\/metronidazole for the prophylaxis of infection after elective colorectal surgery: a randomised double-blind multicentre trial in 517 patients","volume":"158","author":"And\u00e5ker","year":"1992","journal-title":"Eur J Surg"},{"key":"10.1016\/j.ijid.2011.07.007_bib0435","first-page":"185","article-title":"Stratified duration of prophylactic antimicrobial treatment in emergency abdominal surgery. Metronidazole\u2013fosfomycin vs. metronidazole\u2013gentamicin in 381 patients","volume":"153","author":"And\u00e5ker","year":"1987","journal-title":"Acta Chir Scand"},{"key":"10.1016\/j.ijid.2011.07.007_bib0440","first-page":"77","article-title":"Antibiotic prophylaxis using a combination of pefloxacin and fosfomycin in heart surgery with CEC (extracorporeal circulation) in patients allergic to beta-lactams","volume":"37","author":"Lebreton","year":"1989","journal-title":"Cah Anesthesiol"},{"key":"10.1016\/j.ijid.2011.07.007_bib0445","first-page":"317","article-title":"Comparison of systemic prophylaxis with metronidazole\/placebo and metronidazole\/fosfomycin in colorectal surgery. A clinical study demonstrating the need for additional anti-aerobic prophylactic cover","volume":"150","author":"Lindhagen","year":"1984","journal-title":"Acta Chir Scand"},{"key":"10.1016\/j.ijid.2011.07.007_bib0450","first-page":"223","article-title":"Prophylactic single-dose fosfomycin and metronidazole compared with neomycin, bacitracin, metronidazole and ampicillin in elective colorectal operations","volume":"156","author":"N\u00f8hr","year":"1990","journal-title":"Acta Chir Scand"},{"key":"10.1016\/j.ijid.2011.07.007_bib0455","first-page":"417","article-title":"Prophylactic effect of fosfomycin on postoperative infection in gastroenterological surgery","volume":"59","author":"Shinagawa","year":"2006","journal-title":"Jpn J Antibiot"},{"key":"10.1016\/j.ijid.2011.07.007_bib0460","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.anai.2010.07.004","article-title":"Anaphylaxis induced by fosfomycin","volume":"105","author":"S\u00e1nchez-Morillas","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.ijid.2011.07.007_bib0465","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2165\/00003495-199753040-00007","article-title":"Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections","volume":"53","author":"Patel","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.ijid.2011.07.007_bib0470","first-page":"4079","article-title":"Effect of fosfomycin on respiration by rat kidney mitochondria","volume":"69","author":"Bedirdjian","year":"1978","journal-title":"Minerva Med"},{"key":"10.1016\/j.ijid.2011.07.007_bib0475","first-page":"77","article-title":"Analysis of oral fosfomycin calcium (Fosmicin) side-effects after marketing","volume":"31","author":"Mayama","year":"1993","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1016\/j.ijid.2011.07.007_bib0480","unstructured":"Available at: http:\/\/www.drugs.com\/drug-interactions\/fosfomycin.html [accessed day September 15, 2011]."},{"key":"10.1016\/j.ijid.2011.07.007_bib0485","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/BF01708239","article-title":"Effect of different combinations of sparfloxacin, oxacillin, and fosfomycin against methicillin-resistant staphylococci","volume":"16","author":"Ferrara","year":"1997","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2011.07.007_bib0490","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/jac\/33.6.1155","article-title":"Effect of combination of oxacillin and non-beta-lactam antibiotics on methicillin-resistant Staphylococcus aureus","volume":"33","author":"Komatsuzawa","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0495","first-page":"252","article-title":"In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin susceptible Staphylococcus aureus","volume":"19","author":"Sahuquillo Arce","year":"2006","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.ijid.2011.07.007_bib0500","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0732-8893(92)90045-U","article-title":"In vivo activity of the combination of daptomycin and fosfomycin compared with daptomycin alone against a strain of Enterococcus faecalis with high-level gentamicin resistance in the rat endocarditis model","volume":"15","author":"Rice","year":"1992","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2011.07.007_bib0505","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/ja.2010.105","article-title":"In vitro activity of two old antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus","volume":"63","author":"Yu","year":"2010","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.ijid.2011.07.007_bib0510","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/jac\/4.6.569","article-title":"Interaction of fosfomycin with other antimicrobial agents: in vitro and vivo studies","volume":"4","author":"Olay","year":"1978","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0515","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s101560050022","article-title":"Activities of \u03b2-lactams, fluoroquinolones, amikacin and fosfomycin alone and in combination against Pseudomonas aeruginosa isolated from complicated urinary tract infections","volume":"5","author":"Hayami","year":"1999","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0520","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ijantimicag.2009.08.013","article-title":"Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections","volume":"34","author":"Roussos","year":"2009","journal-title":"J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2011.07.007_bib0525","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1128\/AAC.37.12.2684","article-title":"Immunosuppressive activity of fosfomycin on human T-lymphocyte function in vitro","volume":"37","author":"Morikawa","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0530","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0162-3109(98)00003-4","article-title":"Fosfomycin (FOM: 1 R-2S-epoxypropylphosphonic acid) suppress the production of IL-8 from monocytes via the suppression of neutrophil function","volume":"39","author":"Honda","year":"1998","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.ijid.2011.07.007_bib0535","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1128\/AAC.41.2.308","article-title":"Immunomodulating effect of fosfomycin on gut-derived sepsis caused by Pseudomonas aeruginosa in mice","volume":"41","author":"Matsumoto","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0540","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1128\/AAC.40.6.1366","article-title":"Modulatory effect of antibiotics on cytokine production by human monocytes in vitro","volume":"40","author":"Morikawa","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0545","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0924-8579(01)00457-5","article-title":"Modulatory effect of macrolide antibiotics on the Th1- and Th2-type cytokine production","volume":"19","author":"Morikawa","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2011.07.007_bib0550","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/AAC.43.3.697","article-title":"Fosfomycin alters lipopolysaccharide-induced inflammatory cytokine production in mice","volume":"43","author":"Matsumoto","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0555","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1128\/AAC.00914-06","article-title":"Immunomodulatory effects of fosfomycin in experimental human endotoxemia","volume":"51","author":"Sauermann","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2011.07.007_bib0560","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000239323","article-title":"Enhancement of the susceptibility of Staphylococcus aureus to phagocytosis after treatment with fosfomycin compared with other antimicrobial agents","volume":"41","author":"P\u00e9rez Fern\u00e1ndez","year":"1995","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijid.2011.07.007_bib0565","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/039463200802100117","article-title":"Role of fosfomycin tromethamine in modulating non-specific defence mechanisms in chronic uremic patients towards ESBL-producing Escherichia coli","volume":"21","author":"Tullio","year":"2008","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.ijid.2011.07.007_bib0570","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/jac\/47.2.141","article-title":"The effect of fosfomycin on neutrophil function","volume":"47","author":"Krause","year":"2001","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971211001664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971211001664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,16]],"date-time":"2019-06-16T13:11:22Z","timestamp":1560690682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971211001664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":114,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S1201971211001664"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2011.07.007","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}